We have located links that may give you full text access.
English Abstract
Journal Article
[Gallbladder epidermoid carcinoma].
Revista Médica de Chile 2018 December
BACKGROUND: Gallbladder epidermoid carcinoma is rare and more common in women over 55 years of age.
AIM: To report the features of 15 patients with gallbladder epidermoid carcinoma.
MATERIAL AND METHODS: Review of medical records of patients with gallbladder cancer in an oncology service.
RESULTS: Of 207 patients with gallbladder cancer, 15patients aged 53-72years, 93% women had an epidermoid component in their cancer. Forty percent were diabetic and 33% had cholelithiasis. All had locoregional extension of the tumor. A cholecystectomy was done in nine patients (using open surgery in six). In six patients, only a biopsy was done. Median survival was 4.2 months.
CONCLUSIONS: Gallbladder epidermoid carcinoma is uncommon and has a bad prognosis.
AIM: To report the features of 15 patients with gallbladder epidermoid carcinoma.
MATERIAL AND METHODS: Review of medical records of patients with gallbladder cancer in an oncology service.
RESULTS: Of 207 patients with gallbladder cancer, 15patients aged 53-72years, 93% women had an epidermoid component in their cancer. Forty percent were diabetic and 33% had cholelithiasis. All had locoregional extension of the tumor. A cholecystectomy was done in nine patients (using open surgery in six). In six patients, only a biopsy was done. Median survival was 4.2 months.
CONCLUSIONS: Gallbladder epidermoid carcinoma is uncommon and has a bad prognosis.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app